Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial - Magnolo N; Soung J; Frew J; Costanzo A; Ruiz-Santiago H; Eyerich K; Llamas-Velasco M; Bukhalo M; Sivamani RK; Moore A; Wu T; Xie J; et al. (Dermatology and Therapy, 2026)